2, 3, 6 -TRIAMINO SUBSTITUTED PYRIDINES AS KV7 (KCNQ) CHANNEL MODULATORS
    1.
    发明公开
    2, 3, 6 -TRIAMINO SUBSTITUTED PYRIDINES AS KV7 (KCNQ) CHANNEL MODULATORS 审中-公开
    作为KV7(KCNQ)通道调节剂的2,3,6-三取代氨基取代的吡啶

    公开(公告)号:EP2475656A1

    公开(公告)日:2012-07-18

    申请号:EP10748096.4

    申请日:2010-09-02

    申请人: NeuroSearch A/S

    IPC分类号: C07D405/14 C07D413/14

    CPC分类号: C07D413/14 C07D405/14

    摘要: The present application relates to novel substituted aminopyridine derivatives, to their use in therapy, to pharmaceutical compositions comprising the derivatives, to the use of said derivatives in the manufacture of a medicament, and to therapeutic methods comprising the administration of the derivatives. The present derivatives are useful for treating a disorder responsive to activation of K
    V 7 channels. Due to the distribution of K
    V 7 channels within the organism, K
    V 7 channel modulators are considered potentially useful for the treatment or alleviation of conditions as diverse as CNS disorders, psychiatric disorders, CNS damage caused by trauma, stroke or neurodegenerative illness or diseases, a variety of neuronal hyperexcitability disorders and conditions, epilepsy, pain, neuropathic pain, migraine, tension type headache, learning and cognitive disorders, motion and motor disorders, multiple sclerosis, cardiac disorders, heart failure, cardio-myopathia, inflammatory diseases, ophthalmic conditions, deafness, progressive hearing loss, tinnitus, obstructive or inflammatory airway diseases, for inducing or maintaining bladder control including the treatment or prevention of urinary incontinence.

    摘要翻译: 本申请涉及新的取代的氨基吡啶衍生物,其在治疗中的用途,包含所述衍生物的药物组合物,所述衍生物在制备药物中的用途,以及包括所述衍生物的施用的治疗方法。 本发明衍生物可用于治疗对K V7通道活化有反应的病症。 由于生物体内K V7通道的分布,K V7通道调节剂被认为可能用于治疗或缓解各种病症,如中枢神经系统疾病,精神疾病,由创伤,中风或神经退行性疾病或疾病引起的CNS损伤, 癫痫症,疼痛,神经性疼痛,偏头痛,紧张型头痛,学习和认知障碍,运动和运动障碍,多发性硬化症,心脏病,心力衰竭,心 - 肌病,炎性疾病,眼科病症, 耳聋,进行性听力丧失,耳鸣,阻塞性或炎性气道疾病,用于诱导或维持膀胱控制,包括治疗或预防尿失禁。